One blank check company, Capitol Investment Corp. IV, is on the IPO calendar for the week ahead to raise $350 million. The slowdown in IPO activity marks the start of the annual August lull. Aside from the one SPAC, there will likely be no IPOs for the next four...read more
After two slow weeks, IPO pricing activity picked up with four companies raising a combined $466 million. Investors remain discerning despite the increased activity; a Cellectis spinoff and a mortgage REIT both priced below their midpoints, and a yoga studio...read more
Kala Pharmaceuticals, a late-stage biotech developing nanoparticle therapies for ocular inflammation, raised $90 million by offering 6 million shares at $15, within the range of $14 to $16. Kala Pharmaceuticals plans to list on the Nasdaq under the symbol...read more
A diverse group of six deals are on the IPO calendar to raise nearly $1 billion in the week ahead. A few deals appear ready to launch, including online real estate broker...read more
US IPO Week Ahead: 1 SPAC on the calendar as August slowdown sets in
One blank check company, Capitol Investment Corp. IV, is on the IPO calendar for the week ahead to raise $350 million. The slowdown in IPO activity marks the start of the annual August lull. Aside from the one SPAC, there will likely be no IPOs for the next four...read more
US IPO Weekly Recap: Investors remain discerning amid increased activity
After two slow weeks, IPO pricing activity picked up with four companies raising a combined $466 million. Investors remain discerning despite the increased activity; a Cellectis spinoff and a mortgage REIT both priced below their midpoints, and a yoga studio...read more
Kala Pharmaceuticals prices IPO at $15, within the range
Kala Pharmaceuticals, a late-stage biotech developing nanoparticle therapies for ocular inflammation, raised $90 million by offering 6 million shares at $15, within the range of $14 to $16. Kala Pharmaceuticals plans to list on the Nasdaq under the symbol...read more
US IPO Week Ahead: Diverse 6-IPO week has yoga, pet meds and gene-edited crops
A diverse group of six deals are on the IPO calendar to raise nearly $1 billion in the week ahead. A few deals appear ready to launch, including online real estate broker...read more